These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33921467)

  • 1. Simultaneous Visualization of
    Borgna F; Barritt P; Grundler PV; Talip Z; Cohrs S; Zeevaart JR; Köster U; Schibli R; van der Meulen NP; Müller C
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33921467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms.
    Borgna F; Haller S; Rodriguez JMM; Ginj M; Grundler PV; Zeevaart JR; Köster U; Schibli R; van der Meulen NP; Müller C
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1113-1126. PubMed ID: 34625828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the tolerability of
    Busslinger SD; Mapanao AK; Kegler K; Bernhardt P; Flühmann F; Fricke J; Zeevaart JR; Köster U; van der Meulen NP; Schibli R; Müller C
    Eur J Nucl Med Mol Imaging; 2024 Jul; ():. PubMed ID: 39046521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β- radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivative.
    Müller C; Zhernosekov K; Köster U; Johnston K; Dorrer H; Hohn A; van der Walt NT; Türler A; Schibli R
    J Nucl Med; 2012 Dec; 53(12):1951-9. PubMed ID: 23139086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclotron production and radiochemical purification of terbium-155 for SPECT imaging.
    Favaretto C; Talip Z; Borgna F; Grundler PV; Dellepiane G; Sommerhalder A; Zhang H; Schibli R; Braccini S; Müller C; van der Meulen NP
    EJNMMI Radiopharm Chem; 2021 Nov; 6(1):37. PubMed ID: 34778932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabeled bicyclic somatostatin-based analogs: a novel class of potential radiotracers for SPECT/PET of neuroendocrine tumors.
    Fani M; Mueller A; Tamma ML; Nicolas G; Rink HR; Cescato R; Reubi JC; Maecke HR
    J Nucl Med; 2010 Nov; 51(11):1771-9. PubMed ID: 20956465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct in vitro and in vivo comparison of (161)Tb and (177)Lu using a tumour-targeting folate conjugate.
    Müller C; Reber J; Haller S; Dorrer H; Bernhardt P; Zhernosekov K; Türler A; Schibli R
    Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):476-85. PubMed ID: 24100768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-isotope 111In/177Lu SPECT imaging as a tool in molecular imaging tracer design.
    Hijnen NM; de Vries A; Nicolay K; Grüll H
    Contrast Media Mol Imaging; 2012; 7(2):214-22. PubMed ID: 22434634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, preparation and biological evaluation of a
    Behnammanesh H; Jokar S; Erfani M; Geramifar P; Sabzevari O; Amini M; Mazidi SM; Hajiramezanali M; Beiki D
    Bioorg Chem; 2020 Jan; 94():103381. PubMed ID: 31662215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer.
    Müller C; Umbricht CA; Gracheva N; Tschan VJ; Pellegrini G; Bernhardt P; Zeevaart JR; Köster U; Schibli R; van der Meulen NP
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1919-1930. PubMed ID: 31134301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application.
    Müller C; Domnanich KA; Umbricht CA; van der Meulen NP
    Br J Radiol; 2018 Nov; 91(1091):20180074. PubMed ID: 29658792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy.
    de Jong M; Breeman WA; Bernard BF; Bakker WH; Schaar M; van Gameren A; Bugaj JE; Erion J; Schmidt M; Srinivasan A; Krenning EP
    Int J Cancer; 2001 Jun; 92(5):628-33. PubMed ID: 11340564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical in vivo application of (152)Tb-DOTANOC: a radiolanthanide for PET imaging.
    Müller C; Vermeulen C; Johnston K; Köster U; Schmid R; Türler A; van der Meulen NP
    EJNMMI Res; 2016 Dec; 6(1):35. PubMed ID: 27108447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Therapeutic Response to Treatment with a 177Lu-Labeled Somatostatin Receptor Agonist and Antagonist in Preclinical Models.
    Dalm SU; Nonnekens J; Doeswijk GN; de Blois E; van Gent DC; Konijnenberg MW; de Jong M
    J Nucl Med; 2016 Feb; 57(2):260-5. PubMed ID: 26514177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future prospects for SPECT imaging using the radiolanthanide terbium-155 - production and preclinical evaluation in tumor-bearing mice.
    Müller C; Fischer E; Behe M; Köster U; Dorrer H; Reber J; Haller S; Cohrs S; Blanc A; Grünberg J; Bunka M; Zhernosekov K; van der Meulen N; Johnston K; Türler A; Schibli R
    Nucl Med Biol; 2014 May; 41 Suppl():e58-65. PubMed ID: 24360901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution, Pharmacokinetics, and Dosimetry of
    Nicolas GP; Mansi R; McDougall L; Kaufmann J; Bouterfa H; Wild D; Fani M
    J Nucl Med; 2017 Sep; 58(9):1435-1441. PubMed ID: 28450554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The low-energy β(-) and electron emitter (161)Tb as an alternative to (177)Lu for targeted radionuclide therapy.
    Lehenberger S; Barkhausen C; Cohrs S; Fischer E; Grünberg J; Hohn A; Köster U; Schibli R; Türler A; Zhernosekov K
    Nucl Med Biol; 2011 Aug; 38(6):917-24. PubMed ID: 21843788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cobalt-labeled octreotide analogs for molecular imaging and auger electron-based radionuclide therapy.
    Thisgaard H; Olsen BB; Dam JH; Bollen P; Mollenhauer J; Høilund-Carlsen PF
    J Nucl Med; 2014 Aug; 55(8):1311-6. PubMed ID: 24876207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The involvement of selected membrane transport mechanisms in the cellular uptake of (177)Lu-labeled bombesin, somatostatin and gastrin analogues.
    Volková M; Mandíková J; Lázníčková A; Lázníček M; Bárta P; Trejtnar F
    Nucl Med Biol; 2015 Jan; 42(1):1-7. PubMed ID: 25288534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose Deposits from 90Y, 177Lu, 111In, and 161Tb in Micrometastases of Various Sizes: Implications for Radiopharmaceutical Therapy.
    Hindié E; Zanotti-Fregonara P; Quinto MA; Morgat C; Champion C
    J Nucl Med; 2016 May; 57(5):759-64. PubMed ID: 26912441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.